New tool could help patients stay safe on lithium
NCT ID NCT06033326
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a French version of a questionnaire that measures how much patients know about lithium, a drug used for bipolar and schizoaffective disorders. Researchers wanted to see if higher knowledge scores matched safe lithium levels in the blood. The study included 22 hospitalized patients who completed the questionnaire twice.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could provide a reliable tool for doctors to assess patient understanding of lithium, helping to improve treatment safety and effectiveness.
- What could go wrong
- This is a small, terminated observational study, so results may not be conclusive or widely applicable. The questionnaire's accuracy depends on patient honesty and cognitive ability.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
chu de Lille
Lille, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an Anti-Seizure drug quiet the brain and sharpen thinking in schizophrenia?
- Can a dissolving film tame agitation in schizophrenia?
- Can a web app get people moving in mental health residential care?
- Brain training and exercise from home: a new hope for early schizophrenia?
- Smartwatch data may forecast bipolar mood swings
- Could a talking therapy ease the weight of bipolar depression?